Knight Therapeutics Inc. (TSE:GUD) to Post FY2025 Earnings of $0.06 Per Share, Raymond James Forecasts

Knight Therapeutics Inc. (TSE:GUD – Free Report) – Raymond James boosted their FY2025 EPS estimates for shares of Knight Therapeutics in a research report issued to clients and investors on Thursday, August 8th. Raymond James analyst R. Sarugaser now anticipates that the company will post earnings per share of $0.06 for the year, up from […]

Leave a Reply

Your email address will not be published.

Previous post Raymond James Brokers Raise Earnings Estimates for STERIS’ (TSE:STE)
Next post CarGurus (NASDAQ:CARG) PT Raised to $32.00